312 related articles for article (PubMed ID: 22682190)
21. [Primary cutaneous mucormycosis: two case reports and review of the literature].
Tapia E O; ChahÃn A C; Concha F C
Rev Chilena Infectol; 2011 Jun; 28(3):269-73. PubMed ID: 21879155
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous zygomycosis in an immunodeficient infant: a case report and review of the literature.
Song KR; Wong MS; Yeung C
Ann Plast Surg; 2008 Apr; 60(4):433-6. PubMed ID: 18362575
[TBL] [Abstract][Full Text] [Related]
23. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases.
Shoham S; Magill SS; Merz WG; Gonzalez C; Seibel N; Buchanan WL; Knudsen TA; Sarkisova TA; Walsh TJ
Med Mycol; 2010 May; 48(3):511-7. PubMed ID: 19824881
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous zygomycosis in an infant with Pearson syndrome.
Kefala-Agoropoulou K; Farmaki E; Tsiouris J; Roilides E; Velegraki A
Pediatr Blood Cancer; 2008 Apr; 50(4):939-40. PubMed ID: 17914738
[No Abstract] [Full Text] [Related]
25. Review of treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.
Vazquez JA
Clin Adv Hematol Oncol; 2005 Oct; 3(10):777-8. PubMed ID: 16258488
[No Abstract] [Full Text] [Related]
26. Cutaneous zygomycosis at catheter insertion site in AML-M4Eo.
Mueller BU; Pabst T
Ann Hematol; 2006 Mar; 85(3):194-5. PubMed ID: 16391910
[No Abstract] [Full Text] [Related]
27. Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery.
Revankar SG; Hasan MS; Smith JW
Med Mycol; 2007 Mar; 45(2):183-5. PubMed ID: 17365655
[TBL] [Abstract][Full Text] [Related]
28. Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.
Leather HL; Correll TA; Meyer CL; Schmalfuss IM; Wingard JR
Clin Adv Hematol Oncol; 2005 Oct; 3(10):773-7. PubMed ID: 16258487
[No Abstract] [Full Text] [Related]
29. [Invasive zygomycosis in patients treated for haematological malignancies].
Verweij PE; van der Velden WJ; Donnelly JP; Blijlevens NM; Warris A
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2597-602. PubMed ID: 18161258
[TBL] [Abstract][Full Text] [Related]
30. Acute wound closure and reconstruction following head zygomycosis: presentation of two cases and review of literature.
Adler N; Seitz IA; Gottlieb LJ
J Reconstr Microsurg; 2008 Oct; 24(7):507-13. PubMed ID: 18798145
[TBL] [Abstract][Full Text] [Related]
31. Importance of identification of zygomycetes in the era of newer antifungal agents.
Bal AM
Transpl Infect Dis; 2006 Jun; 8(2):122-3. PubMed ID: 16734636
[No Abstract] [Full Text] [Related]
32. Zygomycosis and diabetes mellitus.
Lanternier F; Lortholary O
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():21-5. PubMed ID: 19754752
[TBL] [Abstract][Full Text] [Related]
33. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Paul S; Marty FM; Colson YL
Ann Thorac Surg; 2006 Jul; 82(1):338-40. PubMed ID: 16798251
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B.
Vazquez L; Mateos JJ; Sanz-Rodriguez C; Perez E; Caballero D; San Miguel JF
Haematologica; 2005 Dec; 90(12 Suppl):ECR39. PubMed ID: 16464754
[TBL] [Abstract][Full Text] [Related]
35. Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis.
Tragiannidis A; Groll AH
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():82-6. PubMed ID: 19754764
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous zygomycosis secondary to minor trauma in an immunocompromised pediatric patient: a case report.
Sirignano S; Blake P; Turrentine JE; Dominguez AR
Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945642
[TBL] [Abstract][Full Text] [Related]
37. Ten years' experience in zygomycosis at a tertiary care centre in India.
Chakrabarti A; Das A; Sharma A; Panda N; Das S; Gupta KL; Sakhuja V
J Infect; 2001 May; 42(4):261-6. PubMed ID: 11545569
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of cutaneous zygomycosis with extensive surgical debridement and oral posaconazole in an immunocompetent patient.
Laza-Stanca V; Reid L; Watson JD; Williamson EC
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1259-61. PubMed ID: 22391464
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
Spreghini E; Orlando F; Giannini D; Barchiesi F
J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
[TBL] [Abstract][Full Text] [Related]
40. Lipid formulations of amphotericin B as first-line treatment of zygomycosis.
Petrikkos GL
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():87-92. PubMed ID: 19754765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
